Sergio E Baranzini

48PUBLICATIONS
352CO-AUTHORS
Medical mycologyRadiation therapyWomen's studies (incl. girls' studies)Regenerative medicine (incl. stem cells)Preventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Jun 01, 2026
Microbiome-derived metabolites from vitamin B2 and B9 pathways modulate MAIT cells from multiple sclerosis patients.

|Apr 08, 2026
Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence".

Gabriel Cerono, Bruce A C Cree, Stephen L Hauser

|Apr 03, 2026
Female-enriched Eggerthella lenta drives neuroinflammation and IFN-γ via host receptor TLR2.

Rachel R Rock, Margaret Alexander, Cecilia Noecker

|Feb 11, 2026
Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence".

Gabriel Cerono, Bruce A C Cree, Stephen L Hauser

|Jan 21, 2026
In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis.

Nadjet Gacem, Svetlana Bezukladova, Farina Windener

|Dec 27, 2025
Toward a global research agenda for preventing multiple sclerosis.

Ruth Ann Marrie, Ruth Dobson, Sergio E Baranzini

Pageof 8

Frequent Collaborators

12 joint publications

Stephen L Hauser

5 joint publications

Michael R Wilson

5 joint publications

Bruce A C Cree

5 joint publications

Adil Harroud